Praziquantel Pregnancy and Breastfeeding Warnings
Praziquantel is also known as: Biltricide
Praziquantel Pregnancy Warnings
Praziquantel has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of teratogenicity associated with praziquantel when given in doses up to 40 times the normal human dose. There are no controlled data in human pregnancy. Praziquantel should only be given during pregnancy when need has been clearly established.
Praziquantel Breastfeeding Warnings
Praziquantel is excreted into human milk in small amounts. Human milk concentrations equal approximately 25% of the mother's serum concentration. The effects in the nursing infant are unknown. The manufacturer recommends that women should not breast-feed on the day of praziquantel treatment and during the subsequent 72 hours.
The mean excretion of praziquantel in milk, in 10 lactating women, was less than 0.1% of the dose.
See Also...
- Praziquantel use while Breastfeeding (in more detail)
- praziquantel Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
